- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02457481
An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro
August 27, 2018 updated by: National Foundation for Fertility Research
The purpose of this research study is to evaluate a newly developed embryo culture media system for human clinical use in ART.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Egg retrieval will be performed as per standard operating procedures.
Eggs from a single patient are mixed together in a single group during the normal recovery and washing procedure following egg retrieval.
The single group of eggs will be divided in half, then the embryologist will randomly place each half into one of the two culture media treatments, commercial or experimental.
All mature eggs collected at retrieval will undergo fertilization per standard operating procedures according to physician recommendations.
After fertilization (day 0), standard procedures involve in vitro embryo culture in a sequential two step media system.
After confirmation of fertilization success on day 1, embryos are cultured until day 3 in step 1 medium (both commercial and experimental media are two step sequential culture systems).
On day 3, embryos are evaluated and moved from step one to step two culture medium.
On day 5 and day 6, embryo development will be assessed.
Good quality blastocysts will either be transferred fresh or cryopreserved for later transfer and/or genetic testing.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Lone Tree, Colorado, United States, 80124
- Fertility Laboratories of Colorado
-
Lone Tree, Colorado, United States, 80124
- National Fooundation for Fertility Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Adult women of any age who come to Colorado Center for Reproductive Medicine for fertility treatment using IVF.
- Patients can be of any race, culture, sexual orientation or ethnicity.
Exclusion Criteria:
- Minors are excluded from the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Embryo Culture medium
Embryos from each patient are randomly allocated to culture in the commercial or experimental embryo culture medium (half of the embryos in commercial and half in experimental medium).
|
Two step sequential embryo culture medium system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
embryo development
Time Frame: 7 days after egg retrieval
|
Blastocyst development and quality on days 5 and 6 of culture
|
7 days after egg retrieval
|
|
pregnancy rate
Time Frame: 2 months after egg retrieval
|
The incidence of implantation and pregnancy following embryo transfer, including initial pregnancy test and ultrasound examination.
|
2 months after egg retrieval
|
|
offspring weight
Time Frame: 1 year after egg retrieval
|
The birth weight of children born
|
1 year after egg retrieval
|
|
offspring gender
Time Frame: 1 year after egg retrieval
|
The gender of children born
|
1 year after egg retrieval
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fertilization
Time Frame: 2 days after egg retrieval
|
the percentage of mature eggs that successfully fertilized normally
|
2 days after egg retrieval
|
|
euploid embryos
Time Frame: 1 month after egg retrieval
|
For patients undergoing comprehensive chromosome screening, percent normal euploid blastocysts
|
1 month after egg retrieval
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rebecca L Krisher, PhD, NFFR
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
May 13, 2015
First Submitted That Met QC Criteria
May 28, 2015
First Posted (Estimate)
May 29, 2015
Study Record Updates
Last Update Posted (Actual)
August 28, 2018
Last Update Submitted That Met QC Criteria
August 27, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NFFR-OEC-2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on Embryo Culture medium
-
University Hospital, GasthuisbergCompleted
-
Texas Health ResourcesCompletedInfertility | In Vitro Fertilization | Pregnancy Outcome, Live BirthUnited States
-
Instituto Valenciano de Infertilidade de LisboaUniversidade Nova de LisboaCompleted
-
Bruce Shapiro M.D.Withdrawn
-
Federal University of Minas GeraisCompleted
-
VitrolifeCompletedInfertilityUnited States, Sweden
-
University Hospital, BordeauxProgramme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)Active, not recruiting
-
Ibn Sina HospitalBanoon IVF Center; Quena IVF Center; Amshag IVF CenterCompleted
-
The First Affiliated Hospital with Nanjing Medical...RecruitingFertility Issues | Embryo Culture | Blastocyst IVFChina
-
Federal University of São PauloIncept BiosystemsUnknown